These proatherogenic properties of MCP-1 are well documented [8,9,10], and the elevated circulating level of this chemokine was associated with a higher risk of stroke [18] and with histopathological markers of plaque instability [21]. This evidence concerns the gene CCL2 and stroke disorder.